SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Matthew Faber resigned from Tri-County Financial Group's Board of Directors, effective June 11, 2026. The filing discloses a director departure under Item 5.02, with explicit confirmation that the resignation was not due to disagreement with the Company. Board departures are material events affecting the composition of the registrant's governance structure.
View raw filing on EDGAR →The filing discloses announcement of initial cash dividends on the Company's 9.50% Series A Perpetual Preferred Stock via press release under Item 7.01 (Regulation FD Disclosure). While dividend announcements are routine for mature companies, the initiation of dividends on preferred stock—particularly at a 9.50% rate—signals capital structure changes and cash distribution policy that would be material to investors assessing the registrant's financial position and capital allocation strategy. However, the lack of detail in the 8-K body itself (the actual press release is attached as an exhibit) and the use of Item 7.01 (rather than a more specific Item) creates some ambiguity about whether this is a routine preferred dividend announcement or a more significant capital event.
View raw filing on EDGAR →The filing discloses results of an annual stockholder meeting held on June 11, 2026, under Item 5.07. The company reports voting outcomes for three matters: election of six directors (with detailed vote tallies for each nominee), ratification of Eide Bailly LLP as independent auditor, and approval of a certificate amendment to increase authorized common shares to 35,000,000. All three proposals passed with substantial majorities, making this a standard shareholder vote results disclosure.
View raw filing on EDGAR →The filing discloses Item 3.01 regarding a Nasdaq compliance notice dated June 12, 2026. While the notice confirms the Company has now achieved compliance with Listing Rule 5250(c)(1) (periodic filing requirement) and closes a prior non-compliance matter from May 21, 2026, the disclosure itself documents a delisting risk event—the Company had previously failed to satisfy a continued listing standard and received a notice of non-compliance. The resolution of this matter is material to investors as it addresses a direct threat to the Company's continued listing on Nasdaq.
View raw filing on EDGAR →The filing discloses results of Neuraxis, Inc.'s annual meeting of stockholders held on June 10, 2026, under Item 5.07. It reports voting outcomes for four matters: election of six directors (all approved with >96% support), ratification of auditor Rosenberg Rich Baker Berman, P.A., amendment to the 2022 Omnibus Securities and Incentive Plan, and approval of the 2025 Employee Stock Purchase Plan. These are routine but material shareholder governance matters.
View raw filing on EDGAR →The filing discloses Board approval of the 2026 Equity Incentive Plan and grants of stock options to named executive officers (Carlos X. Montoya, Ken Park, Brad Hoffman, John Jubilee, and Patrick White) and other employees/service providers. The disclosure details vesting schedules, performance conditions, and exercise prices for equity awards, which constitutes a compensatory arrangement under Item 5.02(e). This is material as it affects executive compensation structure and potential dilution to shareholders.
View raw filing on EDGAR →The filing's primary disclosure is Item 3.01, which reports MicroVision's application to transfer listing from The Nasdaq Global Market to The Nasdaq Capital Market due to failure to maintain the $1.00 minimum bid price requirement. The company previously received a deficiency notice in January 2026 and now seeks a transfer to avoid delisting, with an additional 180-calendar-day grace period to regain compliance. This is a material delisting-risk event that would significantly affect investor assessment of the company's exchange status and trading continuity.
View raw filing on EDGAR →Venu Holding Corporation entered into an ATM (at-the-market) Sales Agreement with ThinkEquity LLC on June 12, 2026, authorizing the sale of up to $250 million in common stock shares. This is a dilutive equity issuance disclosed under Item 1.01 (Entry into a Material Definitive Agreement). ATM offerings are a classic signal of capital raising at small- and mid-cap issuers and would materially affect investor assessment of share dilution and the company's financing strategy.
View raw filing on EDGAR →Celularity received written notice from Nasdaq on June 9, 2026, that its Market Value of Listed Securities fell below the $35 million minimum required under Nasdaq Listing Rule 5550(b)(2). The company has been granted a 180-day compliance period (until December 7, 2026) to regain compliance, with explicit warning that failure to do so will result in delisting notification. This is a classic delisting risk disclosure under Item 3.01, material to any investor assessing the company's continued public market access.
View raw filing on EDGAR →Item 3.01 discloses that NYSE American's Regulatory Staff determined Perfect Moment Ltd. failed to regain compliance with minimum stockholders' equity requirements by the end of the 18-month compliance period and is "no longer suitable for continued listing." The company's common stock will be suspended from NYSE American during the week of June 15, 2026, and transition to OTC Markets trading. This is a material delisting event that fundamentally affects the registrant's market access and liquidity.
View raw filing on EDGAR →Item 3.02 explicitly discloses an unregistered sale of equity securities (the "Company Shares") issued to Founding Shareholders in a transaction exempt from registration under Section 4(a)(2) and/or Regulation D. The shares are restricted securities under Rule 144. The reference to a Stock Purchase Agreement and the closing of a Purchase Agreement indicates a material equity issuance that would dilute existing shareholders.
View raw filing on EDGAR →The 8-K discloses results of AST SpaceMobile's Annual Meeting held on June 12, 2026, under Item 5.07. The filing reports voting outcomes on three proposals: (i) election of 10 directors, (ii) ratification of KPMG LLP as independent auditor, and (iii) advisory vote on named executive officer compensation. All three proposals passed with substantial majorities, and the detailed vote tallies are provided for each director and proposal.
View raw filing on EDGAR →The filing discloses a securities purchase agreement with 1800 Diagonal Lending for a convertible promissory note with an original issue discount and conversion rights at 61% of the lowest closing bid price over ten trading days, with potential conversion of up to 19.99% of outstanding shares. Item 3.02 explicitly addresses unregistered sales of equity securities under Section 4(a)(2) and Regulation D, and the conversion feature creates significant dilution risk to existing shareholders. This is a classic PIPE-like structure typical of distressed financing at small-cap issuers.
View raw filing on EDGAR →Ocean Capital Acquisition Corp consummated its IPO on June 10, 2026, raising $115 million in gross proceeds ($100 million from the initial offering plus $15 million from the over-allotment option) through entry into material definitive agreements including the Underwriting Agreement, Warrant Agreement, Rights Agreement, Investment Management Trust Agreement, and Sponsor Private Placement Units Purchase Agreement.
View raw filing on EDGAR →The company completed an unregistered private placement of 150,000 units to the Sponsor at $10.00 per unit ($1.5 million aggregate) pursuant to Section 4(a)(2) exemption, simultaneously with the IPO closing.
View raw filing on EDGAR →Three directors—Pok Yu Chow, Hiu Man Cheng, and Hin Wing Wong—were appointed to the Board on May 4, 2026 in connection with the IPO and subsequently appointed to the Audit and Compensation Committees effective June 10, 2026, establishing the governance structure of the newly public company.
View raw filing on EDGAR →William Conkling, Executive Vice President and Chief Financial Officer, resigned effective June 15, 2026. The company disclosed his departure via press release on June 12, 2026, and entered into a separation agreement with consulting fee arrangements.
View raw filing on EDGAR →This is a clear Item 5.07 disclosure of shareholder voting results from Warby Parker's June 8, 2026 Annual Meeting of Stockholders. The filing reports voting outcomes for three proposals: election of three Class II directors (Dave Gilboa, Youngme Moon, and Ronald Williams), ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. All three proposals passed with substantial majorities, making this a material governance event that affects investor understanding of board composition and corporate oversight.
View raw filing on EDGAR →Wheeler Real Estate Investment Trust, Inc. implemented a one-for-four reverse stock split effective June 17, 2026, via amendments to the Company's charter filed with Maryland. This material modification to the rights of security holders affects share structure, trading mechanics, and conversion terms for convertible securities and preferred stock.
View raw filing on EDGAR →Avalo Therapeutics exchanged 4,294.675 shares of Series C Preferred Stock for newly created Series C-1 Preferred Stock in an unregistered transaction with an accredited investor, removing the 4.99% beneficial ownership restriction and allowing the investor to increase ownership to 9.99%. The Series C-1 Preferred Stock includes conversion rights (1,000 shares of Common Stock per preferred share), broad-based weighted average anti-dilution protection, and dividend parity, materially affecting shareholder concentration and dilution risk.
View raw filing on EDGAR →Avalo Therapeutics amended employment agreements for four named executives (CEO Dr. Neil, CFO Sullivan, CMO Dr. Doyle, and CBO Boyd) to modify severance, change-of-control payments, equity acceleration, and 280G tax gross-up provisions.
View raw filing on EDGAR →This Item 1.01 discloses the entry into a material definitive agreement—the Pooling and Servicing Agreement dated May 1, 2026, which established BBCMS Mortgage Trust 2026-5C41 and caused the issuance of commercial mortgage pass-through certificates backed by 33 mortgage loans. The filing also describes a subsequent servicing arrangement change for one loan (The Towers at Cupertino City Center) transferred to a separate BANK 2026-5YR22 securitization as of June 11, 2026. These are material securitization and servicing transactions that would affect investor assessment of the trust's structure and asset composition.
View raw filing on EDGAR →Trinity Biotech entered into an At the Market Offering Agreement with Lucid Capital Markets on June 12, 2026, authorizing the sale of up to $4,352,314 of American Depositary Shares (ADSs). This is a dilutive equity issuance under an ATM program, which allows the company to raise capital through the sale of registered securities at market prices. The filing discloses the material terms, including the 3.0% commission to the sales agent and the underlying registration statement (Form F-3 File No. 333-280391).
View raw filing on EDGAR →The filing discloses a change in the registrant's independent registered public accounting firm: Ernst & Young LLP (EY) will be dismissed effective upon completion of the audit for fiscal year ending June 30, 2027, and Deloitte & Touche LLP has been selected as the new auditor for fiscal year ending June 30, 2028. This is a classic auditor change under Item 4.01, with no adverse circumstances (no disagreements, no reportable events, and no qualified audit opinions noted).
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of Evolus's Annual Meeting of Stockholders held on June 11, 2026. The filing presents voting outcomes for three proposals: election of Class II directors (Brady Stewart and Vikram Malik), ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. All three proposals passed with majority support, and the detailed vote tallies (For/Against/Abstain/Broker Non-Vote) are the core content of the disclosure.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of TheRealReal's June 10, 2026 annual meeting of stockholders. The filing presents voting outcomes for six proposals: election of Class I directors (Caretha Coleman, Karen Katz, Mark McCaffrey), ratification of KPMG LLP as auditor, advisory vote on named executive officer compensation, and three failed management proposals to amend the Certificate of Incorporation. The detailed vote tallies (For, Against, Abstain, Broker Non-Votes) are the hallmark of shareholder vote result disclosures required under Item 5.07.
View raw filing on EDGAR →The filing discloses conclusion of a "strategic review process" via press release on June 12, 2026, but the Item 7.01 disclosure provides no substantive detail about the outcome, recommendations, or implications. Without access to Exhibit 99.1, the specific nature of the strategic review conclusion cannot be determined—it could relate to M&A activity, asset sales, operational restructuring, or other material corporate actions. The materiality and event classification depend critically on the press release content, which is referenced but not excerpted in the Item itself.
View raw filing on EDGAR →The filing discloses Amendment No. 2 to a warrant originally issued under a Securities Purchase Agreement dated March 17, 2026. The amendment reduces the exercise price from $16.00 to $3.00 per share for a 90-day period, substantially increasing the likelihood and incentive for exercise. This modification materially enhances the dilutive potential of the warrant and would affect a reasonable investor's assessment of share dilution and capital structure.
View raw filing on EDGAR →OUTFRONT Media entered into a material definitive agreement on June 12, 2026, to issue $500 million in 6.000% Senior Notes due 2034. This debt issuance represents a material capital structure event with detailed covenant restrictions and default provisions that significantly affect the company's financial position and obligations.
View raw filing on EDGAR →This Item 5.07 disclosure reports the results of Summit Therapeutics' 2026 Annual Meeting of Stockholders held on June 10, 2026, with detailed voting tabulations for four proposals: election of nine directors, ratification of PricewaterhouseCoopers LLP as auditor, non-binding advisory vote on named executive officer compensation, and approval of a stock incentive plan amendment to increase shares by 8,000,000. All proposals were approved by the requisite stockholder vote, making this a clear shareholder vote results disclosure.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from ZipRecruiter's June 9, 2026 Annual Meeting of Stockholders under Item 5.07. The filing reports final voting tallies on three proposals: election of directors (Brie Carere and Mike Gupta), ratification of PricewaterhouseCoopers LLP as independent auditor, and advisory approval of named executive officer compensation. All three proposals passed with substantial majorities, making this a material governance event that affects investor understanding of board composition and corporate oversight.
View raw filing on EDGAR →The filing discloses the closing of an acquisition of ThermoKey S.p.A. by Vertiv's wholly-owned subsidiary. This is a material acquisition event that would affect a reasonable investor's assessment of the company's strategic direction and financial position. The disclosure of the acquisition closing is the principal event, even though it is furnished under Item 7.01 (Regulation FD) rather than the more typical Item 1.01 or 2.01.
View raw filing on EDGAR →HPS Corporate Lending Fund discloses a letter regarding its second quarter 2026 tender offer under Regulation FD. While tender offers can be material to shareholders (affecting liquidity and valuation), this disclosure is limited to furnishing a letter without substantive detail in the 8-K itself. The event does not fit neatly into standard categories (not M&A, not exec-related, not financial restatement), making "other_material" the most appropriate classification, though the materiality assessment reflects uncertainty about the tender offer's significance without seeing the full letter.
View raw filing on EDGAR →The Fund discloses preliminary results of a tender offer for approximately 4.7% of outstanding common shares (2,280,500 shares) that expired June 8, 2026, with purchase price based on NAV as of June 30, 2026. While share repurchases are routine for closed-end funds, a tender offer affecting nearly 5% of shares is a material capital allocation event that would affect investor assessment of the Fund's capital structure and share count. This does not fit neatly into the specific taxonomy categories (not M&A, not dilutive issuance, not a routine administrative matter), warranting classification as other_material.
View raw filing on EDGAR →The filing discloses a dividend declaration on common stock and Series B Preferred Shares via press release under Item 2.02 (Results of Operations and Financial Condition). While dividend declarations are material corporate actions affecting shareholder value, this disclosure does not fit the earnings_release category (which typically reports quarterly/annual financial results) nor any other specific event type. The material nature of dividend declarations to investors warrants classification as other_material rather than a routine administrative disclosure.
View raw filing on EDGAR →This exhibit is a formal Report of Voting Results filed pursuant to National Instrument 51-102 Section 11.3, disclosing the results of Aya Gold & Silver Inc.'s annual shareholders' meeting held on June 12, 2026. It tabulates voting outcomes for three resolutions: election of eight directors, appointment of KPMG LLP as auditors, and an advisory vote on executive compensation. The document explicitly states it is furnished "in accordance with section 11.3 of NI 51-102," confirming it is a mandatory shareholder-vote-results disclosure.
View raw filing on EDGAR →This press release discloses the results of Aya Gold & Silver's annual general meeting of shareholders held on June 12, 2026. It reports detailed voting results for the election of eight director nominees (all approved), the appointment of KPMG LLP as auditors, and an advisory vote on executive compensation. The disclosure includes vote counts and percentages for each director and resolution, which is the core content required for shareholder_vote_results classification.
View raw filing on EDGAR →This disclosure reports the monthly NAV per share for Rithm Perpetual Life Residential Trust as of May 31, 2026, broken down by share class (Class J at $20.1602 and Class E at $20.2647) with detailed asset and liability components. While NAV reporting is routine for closed-end funds and trusts, the disclosure of current NAV per share is material to investors in assessing the fund's value and performance. However, this does not fit neatly into the more specific event categories (it is not an earnings release, impairment, restatement, or other discrete corporate action), making "other_material" the most appropriate classification.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from the June 10, 2026 Annual Meeting of Stockholders, including election of two Class II directors, ratification of auditors, approval of convertible note issuance and warrant conversion rights, and adjournment authority. The filing directly reports voting outcomes with vote counts for each proposal, which is the core content of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →Shareholders voted at the June 11, 2026 annual meeting on three matters: election of two Class I directors (Victor K. Lee and Jeff Zhou), ratification of Ernst & Young LLP as independent auditor, and advisory approval of 2025 named executive officer compensation. Detailed voting tallies including for, against, withheld, abstentions, and broker non-votes were disclosed.
View raw filing on EDGAR →The company announced a quarterly cash dividend of $2.00 per share, representing a material capital allocation decision affecting shareholder returns.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Fortrea Holdings' 2026 Annual Meeting of Stockholders held on June 9, 2026. The filing reports voting outcomes on three proposals: election of directors (Anshul Thakral, Peter M. Neupert, and William J. Sharbaugh), ratification of Deloitte & Touche LLP as independent auditor, and advisory approval of named executive officer compensation. The detailed vote tallies (For, Against, Withheld, Abstained, Broker Non-Votes) are characteristic of Item 5.07 disclosures and are material to investors assessing board composition and governance outcomes.
View raw filing on EDGAR →Forbright completed its initial public offering on June 11, 2026, issuing 7.9 million shares at $18.00 per share for approximately $142.2 million in gross proceeds, and simultaneously amended and restated its certificate of incorporation and bylaws to establish the capital structure and governance framework for the newly public company.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from ACM Research's 2026 Annual Meeting held on June 10, 2026. The filing reports voting outcomes for two proposals: election of four directors (David H. Wang, Haiping Dun, Tracy Liu, and Charles Pappis) and ratification of Ernst & Young Hua Ming LLP as independent auditor for 2026. All four director nominees were elected and the auditor appointment was ratified by substantial majorities, making this a routine but material governance disclosure required under Item 5.07.
View raw filing on EDGAR →Camp4 held its Annual Meeting of Stockholders on June 10, 2026, with shareholders voting on three proposals: election of three Class II directors (Steven Holtzman, Murray Stewart, and Richard Young), ratification of Ernst & Young LLP as independent auditor, and approval of an amendment to the 2024 Equity Incentive Plan to modify the evergreen provision to include pre-funded warrants in the share calculation. All three proposals passed with detailed vote tallies disclosed.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from Comcast's June 10, 2026 annual meeting, covering four proposals: director elections, auditor ratification, advisory compensation vote, and an independent chair proposal. Item 5.07 explicitly requires disclosure of shareholder vote results, and the detailed vote tallies for each proposal constitute material information affecting investor assessment of corporate governance and management accountability.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure of shareholder vote results from GPGI's 2026 Annual Meeting held on June 11, 2026. The filing reports voting outcomes on four proposals: election of four Class II directors, advisory Say-on-Pay approval, Say-on-Frequency determination (annual voting approved), and auditor ratification. All proposals passed with substantial majorities, making this a material disclosure of governance outcomes that investors rely upon to assess board composition and executive compensation oversight.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of Hagerty's 2026 Annual Meeting of Stockholders held on June 9, 2026. The filing presents voting outcomes for four proposals: election of nine directors (all receiving majority affirmative votes), advisory approval of named executive officer compensation, advisory frequency vote on compensation (one year recommended), and ratification of Deloitte & Touche LLP as independent auditor. The detailed vote tallies and broker non-votes are characteristic of shareholder vote result disclosures required under Item 5.07.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Asana's June 8, 2026 Annual Meeting of Stockholders, covering three proposals: election of three Class III directors, ratification of PricewaterhouseCoopers LLP as independent auditor, and advisory approval of named executive officer compensation. The filing presents the final vote tallies for each proposal, which is the quintessential content of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of Ginkgo Bioworks' 2026 annual meeting of shareholders held on June 11, 2026. The filing presents detailed voting results for three proposals: election of six directors (with separate voting by Class A and Class B shareholders), ratification of Deloitte & Touche LLP as independent auditor, and an advisory vote on executive compensation. All three proposals passed with substantial majorities. Shareholder vote results are material to investors as they determine board composition and affirm key governance decisions.
View raw filing on EDGAR →